Douglas Kerr Dyne Therapeutics, Inc. (DYN) insider trading activity

DYN Quotes by TradingView

Douglas Kerr is Chief Medical Officer of Dyne Therapeutics, Inc.. Currently has a direct ownership of 92,815 shares of DYN, which is worth approximately $1.32 Million. The most recent transaction as insider was on Jun 05, 2025, when has been sold 1,342 shares (Common Stock) at a price of $13.35 per share, resulting in proceeds of $17,915. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 92.8K
1.43% 3M change
n/a 12M change
Total Value Held $1.32 Million

Douglas Kerr Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 05 2025
SELL
Open market or private sale
$17,915 $13.35 p/Share
1,342 Reduced 1.43%
92,815 Common Stock
Mar 05 2025
SELL
Open market or private sale
$15,887 $11.83 p/Share
1,343 Reduced 1.41%
94,157 Common Stock
Dec 04 2024
BUY
Grant, award, or other acquisition
-
48,000 Added 33.45%
95,500 Common Stock
Sep 03 2024
BUY
Grant, award, or other acquisition
-
47,500 Added 50.0%
47,500 Common Stock

Also insider at

GBIO
Generation Bio Co. Healthcare
CHIEF MEDICAL OFFICER
DK

Douglas Kerr

Chief Medical Officer
Cambridge, MA

Track Institutional and Insider Activities on DYN

Follow Dyne Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DYN shares.

Notify only if

Insider Trading

Get notified when an Dyne Therapeutics, Inc. insider buys or sells DYN shares.

Notify only if

News

Receive news related to Dyne Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on DYN